Rational Exploration of Novel SDHI Fungicide through an Amide-β-ketonitrile Bioisosteric Replacement Strategy

The identification of succinate dehydrogenase inhibitor (SDHI) fungicides bearing a novel scaffold is of great importance to control pathogenic fungi. Difluoromethyl-pyrazole β-ketonitrile derivatives were rationally designed through an innovative amide-β-ketonitrile bioisosteric replacement strategy and evaluated for their antifungal activities. In preliminary fungicidal screening, our new β-ketonitrile compounds showed outstanding in vitro activity. Compounds A7 and A14 exhibited EC₅₀ values of 0.116 and 0.165 μg/mL against Sclerotinia sclerotiorum, respectively, and A14 also displayed an EC₅₀ of 0.0774 μg/mL against Rhizoctonia solani. Furthermore, A14 exhibited moderate in vivo protective activity against rice sheath blight on rice plants. Results from SDH enzymatic assays demonstrated that A14 possesses significant inhibitory effect toward porcine heart SDH, with an IC₅₀ value of 0.183 μM, which was 20-fold more potent than that of fluxapyroxad (IC₅₀ = 3.76 μM). A docking study indicated that H-bonds, cation-π interactions, and edge-to-face π-π interactions play key roles in the binding of A14 with R. solani SDH. The CoMSIA model guided the approach to further structural optimizations and indicated that hydrophobic and steric substituents on the benzene ring have decisive effects on the fungicidal activity against R. solani. The present work describes for the first time the successful bioisosteric replacement of the common SDHI amide moiety by a β-ketonitrile group and highlights the potential of β-ketonitriles as an innovative novel SDHI subclass.